Search

Oryzon’s CEO, Dr. Carlos Buesa, will attend the LSX Investival Showcase, to be held on November 13 at at Old Billingsgate in London (UK). Click on link for more info about the LSX Investival Showcase

On the occasion of World One Health Day, we spoke with Rosario Cerrato, Director of Innovation at Ingulados, a technology-based company that researches to improve 'health' by seeking solutions in

BCN HEALTH conducted a retrospective study based on the records of patients hospitalized due to endometriosis and treated in Spanish public and private hospitals between January of 2009 and December

Spain positions itself as one of the leading countries in the field of advanced therapies, both in terms of scientific expertise and the number of clinical trials.

Nanodecal's funding round aims to raise €600,000 to support the development of a rapid test for detecting respiratory superbugs in chronic respiratory patients.

Research and development (R&D) expenses of $3.8 and $12.2 million for the quarter and nine months ended September 30, 2023, respectively

Spain's first Agri-Food Tech-focused Venture Capital fund kicks off with an initial capital of over 40 million, with a maximum target of 80 million, to invest in technological innovation as a solution

VIVEbiotech has received the "Innovacion Empresarial/Business Innovation" award at the XXXII edition of the La Noche de la Empresa Vasca/Basque Business Night for its management model to boost the new

Meet NANODECAL, our new partner. We talked to its CEO, Roberto de la Rica.

The new center- which will be fully operational in mid-2024 – will have a surface area of ​​1,200 m2 and will be equipped with the most cutting-edge technology.

The conference was organised by the UAI (Innovation Support Unit) of the IiSGM (Instituto de Investigación Sanitaria Gregorio Marañón) and was sponsored by GENESIS Biomed, HOFFMANN EITLE and supported

Being this said, at Biobide they have published a new scientific research where it has been validated the Thyroid Disruption (TD) Assay in zebrafish embryos by fluorescence image analysis utilizing

"A forthcoming initiative will help materialize all the benefits of biotechnologies and biomanufacturing, key elements for the competitiveness and modernization of the European Union's industry due to

This momentousinvestment will serve as the catalyst for revolutionizing the landscape of living single cellanalysis.

Spark secures exclusive worldwide rights to SpliceBio’s proprietary Protein Splicing platform to develop, manufacture, and commercialize a gene therapy targeting an undisclosed inherited retinal

At AseBio, we believe that it is crucial to reposition the biotechnology sector as a strategic industry. However, to achieve this, the collaboration of political and social efforts is essential.

The acquisition of aidhere strengthens Sidekick Health’s digital health offering to patients and partners with the world’s leading PDT company